Biomedical Research Education & Training
Faculty Member

Kassim, Adetola, M.B.B.S.
Associate Professor of Medicine

Lab Url: N/A

Phone Number: (615) 936-1803

Email Address:

Kassim, Adetola's picture
Academic history
M.B.B.S., University of Lagos, Nigeria
Residency, North General Hospital, New York
Fellow, Albert Einstein College of Medicine, New York
M.S., Albert Einstein College of Medicine, New York
Post-Doc, Albert Einstein College of Medicine, New York
Fellow, John Hopkins School of Medicine, Maryland

Office Address   Mailing Address

2665 TVC 1301 22nd Avenue South 37232-5505

Research Keywords
Hematologic Malignancies, stem cell transplantation, non-malignant blood disorders, ,Cancer

Research Specialty
stem cell transplant, hematologic malignancies, non-malignant blood disorders, sickle cell

Research Description
Incidence of pulmonary hypertension in adult sickle cell patients. A prospective case-controlled study.

Kassim, A., Sane, P., Billett, H. Tower skill or marrow expansion with pituitary hemosiderosis in beta thalassemia intermedia. Journal of Radiology , Submitted

Kassim, AA, Galadanci, NA, Pruthi, S, DeBaun, MR. How I treat acute strokes and long-term management in sickle cell disease. Blood, 2015

Wolf, RB, Saville, BR, Roberts, DO, Fissell, RB, Kassim, AA, Airewele, G, DeBaun, MR. Factors associated with growth and blood pressure patterns in children with sickle cell anemia: Silent Cerebral Infarct Multi-Center Clinical Trial cohort. Am J Hematol, 90(1), 2-7, 2015

Das-Gupta, E, Greinix, H, Jacobs, R, Zhou, L, Savani, BN, Engelhardt, BG, Kassim, A, Worel, N, Knobler, R, Russell, N, Jagasia, M. Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure. Haematologica, 99(11), 1746-52, 2014

Kassim, AA, DeBaun, MR. The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease. Expert Opin Pharmacother, 15(3), 325-36, 2014

Maheshwari, S, Kassim, A, Yeh, RF, Domm, J, Calder, C, Evans, M, Manes, B, Bruce, K, Brown, V, Ho, R, Frangoul, H, Yang, E. Targeted Busulfan therapy with a steady-state concentration of 600-700???ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant. Bone Marrow Transplant, 49(3), 366-9, 2014

Pauff, JM, Gonzalez, RS, Sajnani, KP, Kassim, A, Jagasia, M. Post-allograft pomalidomide and reversible hepatotoxicity. Bone Marrow Transplant, 49(10), 1341-2, 2014

Pidala, J, Lee, SJ, Ahn, KW, Spellman, S, Wang, HL, Aljurf, M, Askar, M, Dehn, J, Fernandez Vi??a, M, Gratwohl, A, Gupta, V, Hanna, R, Horowitz, MM, Hurley, CK, Inamoto, Y, Kassim, AA, Nishihori, T, Mueller, C, Oudshoorn, M, Petersdorf, EW, Prasad, V, Robinson, J, Saber, W, Schultz, KR, Shaw, B, Storek, J, Wood, WA, Woolfrey, AE, Anasetti, C. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. Blood, 124(16), 2596-606, 2014

Ragon, BK, Clifton, C, Chen, H, Savani, BN, Engelhardt, BG, Kassim, AA, Vaughan, LA, Lucid, C, Jagasia, M. Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy. Biol Blood Marrow Transplant, 20(1), 53-7, 2014

Sengsayadeth, S, Savani, BN, Jagasia, M, Goodman, S, Greer, JP, Chen, H, Chinratanalab, W, Kassim, AA, Engelhardt, BG. Six-month freedom from treatment failure is an important end point for acute GVHD clinical trials. Bone Marrow Transplant, 49(2), 236-40, 2014

Wolf, RB, Kassim, AA, Goodpaster, RL, DeBaun, MR. Nocturnal enuresis in sickle cell disease. Expert Rev Hematol, 7(2), 245-54, 2014

Jagasia, M, Greinix, H, Robin, M, Das-Gupta, E, Jacobs, R, Savani, BN, Engelhardt, BG, Kassim, A, Worel, N, Knobler, R, Russell, N, Socie, G. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis. Biol Blood Marrow Transplant, 19(7), 1129-33, 2013

Kassim, AA, DeBaun, MR. Sickle cell disease, vasculopathy, and therapeutics. Annu Rev Med, 64, 451-66, 2013

Vaughan, LA, Vu, M, Sengsayadeth, S, Lucid, C, Clifton, C, McCarty, K, Hagaman, D, Domm, J, Kassim, A, Chinratanalab, W, Goodman, S, Greer, J, Frangoul, H, Engelhardt, BG, Jagasia, M, Savani, BN. New allergies after cord blood transplantation. Cytotherapy, 15(10), 1259-65, 2013

Chinratanalab, W, Reddy, N, Greer, JP, Morgan, D, Engelhardt, B, Kassim, A, Brandt, SJ, Jagasia, M, Goodman, S, Savani, BN. Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies. Exp Hematol, 40(6), 431-5, 2012

Engelhardt, BG, Jagasia, SM, Crowe, JE, Griffith, ML, Savani, BN, Kassim, AA, Lu, P, Weitkamp, JH, Moore, DJ, Yoder, SM, Rock, MT, Jagasia, M. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood, 119(10), 2417-21, 2012

Engelhardt, BG, Sengsayadeth, SM, Jagasia, M, Savani, BN, Kassim, AA, Lu, P, Shyr, Y, Yoder, SM, Rock, MT, Crowe, JE. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Exp Hematol, 40(12), 974-982.e1, 2012

Hart, AJ, Jagasia, MH, Kim, AS, Mosse, CA, Savani, BN, Kassim, A. Minimal residual disease in myeloma: are we there yet. Biol Blood Marrow Transplant, 18(12), 1790-9, 2012

Jacobs, R, Tran, U, Chen, H, Kassim, A, Engelhardt, BG, Greer, JP, Goodman, SG, Clifton, C, Lucid, C, Vaughan, LA, Savani, BN, Jagasia, M. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant, 47(11), 1470-3, 2012

Reddy, N, Greer, JP, Goodman, S, Kassim, A, Morgan, DS, Chinratanalab, W, Brandt, S, Englehardt, B, Oluwole, O, Jagasia, MH, Savani, BN. Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen. Exp Hematol, 40(5), 359-66, 2012

Sengsayadeth, SM, Jagasia, M, Engelhardt, BG, Kassim, A, Strickland, SA, Goodman, S, Lucid, C, Vnencak-Jones, CL, Greer, JP, Savani, BN. Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Bone Marrow Transplant, 47(12), 1535-7, 2012

Kassim AA, Fabry ME, Nagel RL. Acute priapism associated with the use of sildenafil in a patient with sickle cell trait. (Letter). Blood, 1;95(5), 1878-9, 2000

Kassim AA, Umans H, Nagel RL, Fabry ME. Megalophallus as a sequela of priapism in sickle cell anemia: use of blood oxygen level-dependent magnetic resonance imaging. Urology, 1;56(3), 509, 2000

Fabry, M.E., Liu, G., Kassim, A., Billet, H., Nagel, R.L. Deoxy HbS detection in brain of sickle cell disease patients by blood level oxygen dependent magnetic resonance imaging (BOLD-MRI). (Abstract). Blood(94), 421a, 1999

Fabry, M.E., Kassim, A., Umans, H., Nagel, R.L. Clinical applications of BOLD-MRI to extremities in sickle cell pain episodes. (Abstract). Blood(9, 92), 525a, 1998

Postdoctoral Position Available

Postdoctoral Position Details

Updated Date